Answers are grounded in this paper and cite their sources.
Preclinical evaluation demonstrates effective tumor targeting and pharmacokinetic profile of FAP-targeted radiotracers in glioma.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: